| ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO |
| (State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) | |
| |
||
(Address of principal executive offices) |
(Zip Code) | |
| Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
| Large accelerated filer |
☐ |
|
☒ | |||
| Non-accelerated filer |
☐ |
Smaller reporting company |
| |||
| Emerging growth company |
|
|||||
Table of Contents
| Page | ||||||
| 1 | ||||||
| Item 10. |
1 | |||||
| Item 11. |
10 | |||||
| Item 12. |
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters |
18 | ||||
| Item 13. |
Certain Relationships and Related Transactions, and Director Independence |
21 | ||||
| Item 14. |
29 | |||||
| 30 | ||||||
| Item 15. |
30 | |||||
| Item 16. |
33 | |||||
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Amendment includes forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, about us and our industry that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this Amendment including statements regarding our future results of operations or financial condition, business strategy and plans and objectives of management for future operations, are forward-looking statements. Words including “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “seek,” “should,” “will,” or “would,” or, in each case, the negative thereof or other variations thereon or comparable terminology are intended to identify forward-looking statements. In addition, any statements or information that refer to expectations, beliefs, plans, projections, objectives, performance or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking.
These forward-looking statements include, but are not limited to: statements regarding the Merger Agreement (as defined herein) and the transactions contemplated thereby, the operational and financial results of the Company’s franchisees; the ability of the Company’s franchisees to enter new markets, select appropriate sites for new centers or open new centers; the effectiveness of the Company’s marketing and advertising programs and the active participation of its franchisees in enhancing the value of its brand; the failure of its franchisees to participate in and comply with its agreements, business model and policies; the Company’s and its franchisees’ ability to attract and retain guests; the effect of social media on the Company’s reputation; the Company’s ability to compete with other industry participants and respond to market trends and changes in consumer preferences; the effect of the Company’s planned growth on its management, employees, information systems and internal controls; the Company’s ability to retain or effectively respond to a loss of key executives; recruitment efforts; a significant failure, interruptions or security breach of the Company’s computer systems or information technology; the Company and its franchisees’ ability to attract, train, and retain talented wax specialists and managers; changes in the availability or cost of labor; the Company’s ability to retain its franchisees and to maintain the quality of existing franchisees; failure of the Company’s franchisees to implement business development plans; the ability of the Company’s limited key suppliers, including international suppliers, and distribution centers to deliver their products; changes in supply costs and decreases in the Company’s product sourcing revenue; the Company’s ability to adequately protect its intellectual property; the Company’s substantial indebtedness; the impact of paying some of the Company’s pre-IPO owners for certain tax benefits the Company may claim; changes in general economic and business conditions; the Company’s and its franchisees’ ability to comply with existing and future health, employment and other governmental regulations; complaints or litigation that may adversely affect the Company’s business and reputation; the seasonality of the Company’s business resulting in fluctuations in its results of operations; the impact of global crises on the Company’s operations and financial performance; the impact of inflation and rising interest rates on the Company’s business; the Company’s access to sources of liquidity and capital to finance its continued operations and growth strategy and the other important factors discussed under the caption “Risk Factors” under Item 1A in our Annual Report on Form 10-K for the year ended January 3, 2026, as well as other information we file with the Securities and Exchange Commission (“SEC”).
We caution investors, potential investors and others not to place undue reliance on the forward-looking statements contained in this Amendment. You are encouraged to read any further disclosures we may make in our future reports to the SEC, accessible on the SEC’s website at www.sec.gov, Investors Relations section of the Company’s website at www.waxcenter.com, or otherwise. Our website and information included in or linked to our website are not part of this Amendment.
These and other important factors could cause actual results to differ materially from those indicated by the forward-looking statements made in this Amendment. Any forward-looking statement that the Company makes in this Amendment speaks only as of the date of such statement, and we undertake no obligation to update or revise, or to publicly announce any update or revision to, any of the forward-looking statements, whether as a result of new information, future events or otherwise. Our business is subject to substantial risks and uncertainties, including those referenced above. Investors, potential investors, and others should give careful consideration to these risks and uncertainties.
Name |
Age |
Position | ||
Christopher Morris |
55 |
Chief Executive Officer and Chairman | ||
Alexa Bartlett |
38 |
Director | ||
Andrew Crawford |
47 |
Director | ||
Julia Hunter |
41 |
Director | ||
Dorvin D. Lively |
67 |
Director | ||
Laurie Ann Goldman |
63 |
Director | ||
Nital Scott |
47 |
Director |
Name |
Age |
Position | ||
Christopher Morris |
55 |
Chief Executive Officer and Chairman | ||
Angela Jaskolski |
52 |
Chief Operating Officer | ||
Thomas Kim |
48 |
Chief Financial Officer | ||
Katie Mullen |
45 |
Chief Commercial Officer | ||
Kurt Smith |
46 |
Chief Development Officer | ||
Cindy Thomassee |
54 |
Chief Accounting Officer |
• |
Class I, which consists of Alexa Bartlett and Julia Hunter. The terms of Ms. Bartlett and Ms. Hunter will continue until our 2028 annual meeting of stockholders and a successor is duly elected and qualified or until earlier death, resignation or removal; |
• |
Class II, which consists of Laurie Ann Goldman, Dorvin D. Lively and Nital Scott. The terms of Ms. Goldman, Mr. Lively and Ms. Scott will continue until our 2026 annual meeting of stockholders and a successor is duly elected and qualified or until earlier death, resignation or removal; and |
• |
Class III, which consists of Andrew Crawford and Chris Morris. The terms of Mr. Crawford and Mr. Morris will continue until our 2027 annual meeting of stockholders and a successor is duly elected and qualified or until earlier death, resignation or removal. |
• |
preparing the annual Audit Committee report to be included in our annual proxy statement; |
• |
overseeing and monitoring our accounting and financial reporting processes; |
• |
overseeing and monitoring the integrity of our financial statements and internal control system; |
• |
overseeing and monitoring the independence, retention, performance and compensation of our independent registered public accounting firm; |
• |
overseeing and monitoring the performance, appointment and retention of our internal audit department; |
• |
reviewing and discussing, with management and the internal audit group risk assessment and risk management policies, including risks related to cybersecurity and information technology systems; |
• |
overseeing and monitoring our compliance with legal and regulatory matters; and |
• |
providing regular reports to the Board of Directors. |
• |
reviewing, evaluating and making recommendations to the full Board of Directors regarding our compensation policies and programs; |
• |
reviewing and approving the compensation of our chief executive officer, and recommend to the Board of Directors for approval, the compensation of other executive officers and key employees, including all material benefits, option or stock award grants and perquisites and all material employment agreements; |
• |
reviewing and making recommendations to the Board of Directors with respect to our incentive compensation plans, equity-based compensation plans and retirement plans; |
• |
administering incentive compensation and equity-related plans and retirement plans; |
• |
reviewing and making recommendations to the Board of Directors with respect to policies regarding the recovery or “clawback” of incentive compensation; |
• |
reviewing and making recommendations to the Board of Directors with respect to the financial and other performance targets that must be met; and |
• |
preparing an annual Compensation Committee report and taking such other actions as are necessary and consistent with the governing law and our organizational documents. |
• |
identifying candidates qualified to become directors of the Company, consistent with criteria approved by our Board of Directors; |
• |
recommending to our Board of Directors nominees for election as directors at the next annual meeting of stockholders or a special meeting of stockholders at which directors are to be elected, as well as to recommend directors to serve on the other committees of the Board of Directors; |
• |
recommending to our Board of Directors candidates to fill vacancies and newly created directorships on the board of directors; |
• |
setting and reviewing the compensation of non-executive members of the Board of Directors; |
• |
developing and recommending to our Board of Directors guidelines setting forth corporate governance principles applicable to the Company; |
• |
oversee the Company’s Social Responsibility program, encompassing the Company’s efforts with respect to environmental, social and governance (“ESG”) matters of significance; and |
• |
overseeing the evaluation of our Board of Directors. |
• |
Christopher Morris, our Chief Executive Officer and Chairman; |
• |
David Berg, our former Chief Executive Officer and Executive Chair; |
• |
Thomas Kim, our Chief Financial Officer; and |
• |
Katie Mullen, our Chief Commercial Officer. |
Name and Principal Position |
Year |
Salary ($) |
Bonus ($) (1) |
Stock Awards ($) (2) |
Option Awards ($) (3) |
Nonequity Incentive Plan Compensation ($) (4) |
All Other Compensation (4) (5) |
Total ($) |
||||||||||||||||||||||||
Christopher Morris Chief Executive Officer and Chairman (6) |
2025 |
795,000 |
— |
3,846,000 |
6,844,500 |
763,128 |
3,455 |
12,252,083 |
||||||||||||||||||||||||
David Berg Former Chief Executive Officer and Executive Chair (7) |
2025 2024 |
13,832 311,539 |
— 250,000 |
— 499,993 |
— 3,180,743 |
— 118,423 |
11,719 52,904 |
25,551 4,413,602 |
||||||||||||||||||||||||
Thomas Kim Chief Financial Officer (8) |
2025 |
356,935 |
— |
702,000 |
1,528,125 |
238,324 |
510 |
2,825,894 |
||||||||||||||||||||||||
Katie Mullen Chief Commercial Officer (9) |
2025 |
402,462 |
— |
638,400 |
1,364,400 |
259,378 |
50,580 |
2,715,220 |
||||||||||||||||||||||||
(1) |
The amount reported in this column for 2024 for Mr. Berg represents a bonus received in connection with his appointment as Chief Executive Officer. |
(2) |
The values set forth in this column for 2025 and 2024 represent the grant date fair value of restricted stock unit (“RSU”) awards granted to each of our named executive officers other than Mr. Berg during 2025 and to Mr. Berg during 2024, in each case, computed in accordance with FASB ASC Topic 718, disregarding the effect of estimated forfeitures. The assumptions used to value the RSUs for this purpose are set forth in Note 14 to our consolidated financial statements included in our Annual Report on Form 10-K for fiscal year 2025 and Note 14 to our consolidated financial statements included in our Annual Report on Form 10-K for fiscal year 2024. For RSU awards granted in 2025 and 2024, the grant date fair value was calculated by multiplying the closing price of the underlying shares of Class A common stock on the date of grant by the number of RSUs granted. |
(3) |
The amounts reported in this column represent the aggregate grant date fair value of options to purchase our Class A common stock granted to each of our named executive officers other than Mr. Berg in 2025 and to Mr. Berg during 2024, in each case, computed in accordance with FASB ASC Topic 718, excluding the effects of estimated forfeitures. The assumptions used in the valuation of these awards are set forth in Note 14 to our consolidated financial statements included in our Annual Report on Form 10-K for fiscal year 2025 and Note 14 to our consolidated financial statements included in our Annual Report on Form 10-K for fiscal year 2024. |
(4) |
The amounts reported in this column represent each named executive officer’s annual bonus earned with respect to fiscal years 2025 and 2024, as applicable, based on the attainment of corporate performance goals as described below under “2025 Base Salary and Annual Bonus,” in the case of bonuses earned with respect to fiscal year 2025. |
(5) |
The amounts reported in this column for 2025 include life insurance premium payments for Mr. Morris ($2,224), Mr. Berg ($148), Mr. Kim ($510), and Ms. Mullen ($580); employer matching contributions to our 401(k) plan for Mr. Morris ($1,231); housing expenses for Mr. Berg ($11,571); and consulting fees for Ms. Mullen for the period she was a consultant for us prior to the commencement of her employment ($50,000). The amounts reported in this column for 2024 for Mr. Berg include life insurance premium payments ($2,689); employer matching contributions to our 401(k) plan ($13,800); and housing expenses ($36,415). Other than in the case of Mr. Berg, each named executive officer also received certain personal benefits, the aggregate value of which did not exceed $10,000 for each individual in either year. |
(6) |
Mr. Morris commenced employment on January 8, 2025. |
(7) |
Mr. Berg departed from his position as Chief Executive Officer and Executive Chair of the Board of Directors, effective January 7, 2025, and continued to serve as a member of the Board of Directors until September 10, 2025. |
(8) |
Mr. Kim commenced employment on April 7, 2025. |
(9) |
Ms. Mullen commenced employment on March 5, 2025. She was a consultant for us from January 28, 2025 until her start date. |
Name |
Grant date |
Number of securities underlying the award |
Exercise price of the award ($/Sh) |
Grant date fair value of the award ($) |
Percentage change in the closing market price of the securities underlying the award between the trading day ending immediately prior to the disclosure of material nonpublic information and the trading day beginning immediately following the disclosure of material nonpublic information |
|||||||||||||||
| |
1/8/2025 (1) 1/8/2025 (1) 1/8/2025 (1) |
|
|
|
|
|
|
|
|
% % % | ||||||||||
| |
3/21/2025 (2) 3/21/2025 (2) 3/21/2025 (2) |
|
|
|
|
|
|
|
|
% % % | ||||||||||
| (1) | Our Current Report on Form 8-K disclosing a press release including certain commentary regarding the fiscal year ended January 4, 2025 was filed on January 13, 2025. |
| (2) | Our Current Report on Form 8-K disclosing the approval of the Inducement Plan was filed on March 21, 2025. |
Option awards |
Stock awards |
|||||||||||||||||||||||||||||||
Name |
Number of securities underlying unexercised options (#) exercisable |
Number of securities underlying unexercised options (#) unexercisable |
Option exercise price ($/share) |
Option expiration date |
Number of shares or units of stock that have not vested (#) |
Market value of shares or units of stock that have not vested ($) (1) |
||||||||||||||||||||||||||
Christopher Morris |
— |
425,000 |
12.00 |
1/8/2035 |
(2 |
) |
— |
— |
||||||||||||||||||||||||
— |
425,000 |
9.00 |
1/8/2035 |
(2 |
) |
— |
— |
|||||||||||||||||||||||||
— |
800,000 |
6.41 |
1/8/2035 |
(2 |
) |
— |
— |
|||||||||||||||||||||||||
— |
— |
— |
— |
600,000 |
(3 |
) |
2,064,000 |
|||||||||||||||||||||||||
David Berg(8) |
— |
— |
— |
— |
— |
— |
||||||||||||||||||||||||||
Thomas Kim |
— |
212,500 |
12.00 |
4/7/2035 |
(4 |
) |
— |
— |
||||||||||||||||||||||||
— |
212,500 |
9.00 |
4/7/2035 |
(4 |
) |
— |
— |
|||||||||||||||||||||||||
— |
310,000 |
3.51 |
4/7/2035 |
(4 |
) |
— |
— |
|||||||||||||||||||||||||
— |
— |
— |
— |
200,000 |
(5 |
) |
688,000 |
|||||||||||||||||||||||||
Katie Mullen |
— |
180,000 |
12.00 |
3/21/2035 |
(6 |
) |
— |
— |
||||||||||||||||||||||||
— |
180,000 |
9.00 |
3/21/2035 |
(6 |
) |
— |
— |
|||||||||||||||||||||||||
— |
220,000 |
3.99 |
3/21/2035 |
(6 |
) |
— |
— |
|||||||||||||||||||||||||
— |
— |
— |
— |
160,000 |
(7 |
) |
550,400 |
|||||||||||||||||||||||||
(1) |
Based on the closing price of a share of our Class A common stock ($3.44) on January 2, 2026, the last trading day of fiscal year 2025. |
(2) |
Represents an option to purchase shares of our Class A common stock granted on January 8, 2025 that vests as to 100% of the underlying shares on the fourth anniversary of the date of grant, generally subject to the named executive officer’s continued service through the vesting date and subject to accelerated vesting upon a “change in control” as defined in the 2021 Plan. |
(3) |
Represents RSUs granted on January 8, 2025 that vest in four equal installments on each of the first four anniversaries of the date of grant, generally subject to the named executive officer’s continued employment through the applicable vesting date and subject to accelerated vesting upon a “change in control” as defined in the 2021 Plan. |
(4) |
Represents an option to purchase shares of our Class A common stock granted on April 7, 2025 that vests as to 100% of the underlying shares on the fourth anniversary of the date of grant, generally subject to the named executive officer’s continued service through the vesting date. |
(5) |
Represents RSUs granted on April 7, 2025 that vest in four equal installments on each of the first four anniversaries of the date of grant, generally subject to the named executive officer’s continued employment through the applicable vesting date. |
(6) |
Represents an option to purchase shares of our Class A common stock granted on March 21, 2025 that vests as to 100% of the underlying shares on the fourth anniversary of January 28, 2025, generally subject to the named executive officer’s continued service through the vesting date. |
(7) |
Represents RSUs granted on March 21, 2025 that vest in four equal installments on each of the first four anniversaries of January 28, 2025, generally subject to the named executive officer’s continued employment through the applicable vesting date. |
(8) |
Mr. Berg’s outstanding equity awards were forfeited in connection with his departure from the Company’s Board of Directors on September 10, 2025. |
Name |
Fees earned or paid in cash ($) (1) |
Stock awards ($) (2) |
Total ($) |
|||||||||
Alexa Bartlett |
— |
— |
— |
|||||||||
Andrew Crawford |
— |
— |
— |
|||||||||
Laurie Ann Goldman |
50,000 |
125,000 |
175,000 |
|||||||||
Julia Hunter |
50,000 |
125,000 |
175,000 |
|||||||||
Dorvin D. Lively |
70,000 |
125,000 |
195,000 |
|||||||||
Nital Scott |
50,000 |
125,000 |
175,000 |
|||||||||
(1) |
The amounts reported in this column represent cash fees earned in respect of services that were rendered in fiscal year 2025. In addition to Mr. Lively’s annual cash retainer pursuant to his letter agreement as described below, Mr. Lively received a $20,000 director fee for his role as Chairman of the Audit Committee. |
(2) |
The amounts reported in this column represent the grant date fair value of RSUs granted in fiscal year 2025 to Ms. Goldman, Ms. Hunter, Mr. Lively, and Ms. Scott, computed in accordance with FASB ASC 718, excluding the effects of estimated forfeitures. For RSU awards, the grant date fair value was calculated by multiplying the closing price of the underlying shares of Class A common stock on the date of grant by the number of RSUs granted. As of January 3, 2026, our non-employee directors held the following unvested RSUs: Ms. Goldman, 11,004; Ms. Hunter, 14,092; Mr. Lively, 11,004; and Ms. Scott, 11,004. |
Class A common stock beneficially owned (1) |
Class B common stock beneficially owned |
|||||||||||||||
Name of beneficial |
Number |
Percentage |
Number |
Percentage |
||||||||||||
5% Stockholders |
||||||||||||||||
General Atlantic Equityholders (2) |
22,817,201 |
42.3 |
% |
9,706,709 |
92.3 |
% | ||||||||||
BlackRock, Inc. (3) |
2,718,360 |
6.1 |
% |
— |
— |
|||||||||||
Hilary L. Shane (4) |
2,666,095 |
6.0 |
% |
— |
— |
|||||||||||
Ararat Capital Management LP (5) |
2,218,002 |
5.0 |
% |
— |
— |
|||||||||||
EWC Management Holdco (6) |
812,396 |
1.8 |
% |
812,396 |
7.7 |
% | ||||||||||
Directors and Named Executive Officers |
||||||||||||||||
Christopher Morris |
111,454 |
* |
— |
— |
||||||||||||
Alexa Bartlett |
— |
— |
— |
— |
||||||||||||
Andrew Crawford |
— |
— |
— |
— |
||||||||||||
Julia Hunter |
55,103 |
* |
— |
— |
||||||||||||
Dorvin D. Lively |
84,690 |
* |
— |
— |
||||||||||||
Laurie Ann Goldman |
65,190 |
* |
— |
— |
||||||||||||
Nital Scott |
36,221 |
* |
— |
— |
||||||||||||
Thomas Kim |
50,000 |
* |
— |
— |
||||||||||||
David Berg |
— |
— |
— |
— |
||||||||||||
Katie Mullen |
40,000 |
* |
— |
— |
||||||||||||
All executive officers and directors as a group (12 persons) (7) |
527,448 |
1.2 |
% |
— |
— |
|||||||||||
* |
Less than one percent |
(1) |
Each Opco Post-IPO Member holds Opco Common Units (non-voting common units in Opco) and an equal number of shares of Class B common stock. Each Opco Post-IPO Member has the right at any time to exchange any vested Opco Common Units (together with a corresponding number of shares of Class B common stock) for shares of Class A common stock on a one-for-one |
(2) |
Includes 12,749,506 shares of Class A common stock held directly by GA AIV-1 B Interholdco (EW), L.P., a Delaware limited partnership (“GA AIV-1 B Interholdco EW”), 360,986 shares of Class A common stock and 1,683,464 shares of Class B common stock are held directly by GAPCO AIV Interholdco (EW), L.P., a Delaware limited partnership (“GAPCO AIV Interholdco EW”), and 8,023,245 shares of Class B common stock are held directly by General Atlantic Partners AIV (EW), L.P. (“GAP AIV EW”) representing 41.4% ownership in European Wax Center. The shares held by GA AIV-1 B Interholdco EW, GAPCO AIV Interholdco EW and GAP AIV (EW), a Delaware limited partnership, are indirectly held and shared by the following investment funds (the “GA Funds”): General Atlantic Partners AIV-1 A, L.P., a Delaware limited partnership (“GAP AIV-1 A”), General Atlantic Partners AIV-1 B, L.P., a Delaware limited partnership (“GAP AIV-1 B”), GAP Coinvestments CDA, L.P., a Delaware limited partnership (“GAPCO CDA”), GAP Coinvestments III, LLC, a Delaware limited liability company (“GAPCO III”), GAP Coinvestments IV, LLC, a Delaware limited liability company (“GAPCO IV”), and GAP Coinvestments V, LLC, a Delaware limited liability company (“GAPCO V”). The general partner of GAP AIV EW is General Atlantic GenPar (EW), L.P., a Delaware limited partnership (“GA GenPar EW”). The general partner of GA GenPar EW, GA AIV-1 B Interholdco EW and GAPCO AIV Interholdco EW is General Atlantic (SPV) GP, LLC, a Delaware limited liability company (“GA SPV”). GA LP is ultimately controlled by the Partnership Committee of GASC MGP, LLC (the “GA Partnership Committee”). The general partner of GAP AIV-1 A and GAP AIV-1 B is ultimately controlled by General Atlantic, L.P., a Delaware limited partnership (“GA, L.P.”). GA, L.P. is the sole member of GA SPV, the managing member of GAPCO III, GAPCO IV and GAPCO V and the general partner of GAPCO CDA. GA AIV-1 B Interholdco EW, GAPCO AIV Interholdco EW, GAP AIV EW, the GA Funds, GA GenPar EW, GA SPV, and GA, L.P. (collectively, the “General Atlantic Filing Parties”). The General Atlantic Filing Parties are a “group” within the meaning of Rule 13d-5 of the Exchange Act. |
(3) |
As reported by BlackRock, Inc. on a Schedule 13G filed with the SEC on February 2, 2024, reporting sole voting power with respect to 2,674,440 shares of Class A common stock and sole dispositive power with respect to 2,718,360 shares of Class A common stock. The address for the holder is 50 Hudson Yards, New York, New York 10001. |
(4) |
As reported by Hilary L. Shane on a Schedule 13G filed with the SEC on February 18, 2026. Hilary L. Shane has sole voting power and sole dispositive power with respect to 2,666,095 shares of Class A common stock. Hilary L Shane Revocable Trust has sole voting power and sole dispositive power with respect to 1,508,600 shares of Class A common stock. ODS Capital LLC has sole voting power and sole dispositive power with respect to 1,157,495 shares of Class A common stock. |
(5) |
As reported by Ararat Capital Management LP (“Ararat”) on a Schedule 13G/A filed with the SEC on February 11, 2026. Ararat has shared voting power and shared dispositive power with respect to 2,218,002 shares of Class A common stock. Narrow River Capital Partners Master Fund, L.P. has shared voting power and shared dispositive power with respect to 2,077,603 shares of Class A common stock. Raffi Tokatlian has shared voting power and shared dispositive power with respect to 2,218,002 shares of Class A common stock. |
(6) |
Each member of EWC Management Holdco, the members of which consist of our current and former employees, exercise voting and dispositive control over the shares to which such member is entitled upon exchange of the vested Opco Common Units and corresponding shares of Class B common stock held by EWC Management Holdco. |
(7) |
Includes current executive officers and directors. |
Name |
Number of Securities To Be Issued Upon Exercise of Outstanding Options, Warrants, Rights and Restricted Shares |
Weighted Average Exercise Price of Outstanding Options, Warrants, Rights and Restricted Shares |
Number of Securities Remaining Available for Future Issuance Under Equity Plans (excluding securities listed in first column) |
|||||||||
Equity compensation plans approved by security holders (1) |
3,325,696 |
$ |
8.69 |
(3) |
4,516,707 |
|||||||
Equity compensation plans not approved by security holders (2) |
5,844,000 |
$ |
11.16 |
(4) |
886,000 |
|||||||
Total |
9,169,696 |
$ |
10.56 |
(5) |
5,402,707 |
|||||||
(1) |
Total reflects outstanding stock options and restricted stock units granted pursuant to the European Wax Center, Inc. 2021 Omnibus Incentive Plan. |
(2) |
Total reflects (i) outstanding warrants granted to dolabra holdings llc in consideration for the provision of professional services to the Company and (ii) outstanding stock options and restricted stock units granted pursuant to the European Wax Center, Inc. 2025 Inducement Plan. |
(3) |
Outstanding restricted stock units have no exercise price and are therefore excluded from the weighted average exercise price calculation. |
(4) |
Outstanding restricted shares have no exercise price and are therefore excluded from the weighted average exercise price calculation. |
(5) |
Outstanding restricted stock units and restricted shares have no exercise price and are therefore excluded from the weighted average exercise price calculation. |
• |
we have been or are to be a participant; |
• |
the amount involved exceeded or will exceed $120,000; and |
• |
any of our directors, executive officers or, to our knowledge, beneficial owners of more than 5% of our capital stock or any member of the immediate family of any of the foregoing persons had or will have a direct or indirect material interest. |
• |
any acquisition of the equity securities or assets of any other entity (other than any of our subsidiaries), in a single transaction or a series of related transactions in excess of $100 million and/or the disposition of any of our or our subsidiaries’ equity securities or assets, in a single transaction or a series of related transactions in excess of $100 million; |
• |
entering or effectuating a “Change in Control” as defined in our Stockholders’ Agreement; |
• |
incurring indebtedness of the Company and our subsidiaries to the extent such incurrence would result in the Company and our subsidiaries having indebtedness in excess of $150 million in the aggregate other than a drawdown of amounts committed under a debt agreement that was previously consented to by the General Atlantic Equityholders or that was entered into on or prior to the entry into the Stockholders’ Agreement; |
• |
appointing or removing our chief executive officer; |
• |
any increase or decrease in the size of our Board of Directors; |
• |
any entry by us or our subsidiaries into voluntary liquidation, dissolution, receivership, bankruptcy or other insolvency proceeding, or any recapitalization or reorganization; |
• |
a redemption, repurchase or other acquisition by us of our capital stock (other than any redemption, repurchase or acquisition under any stockholder approved equity compensation plan or pursuant to an offer made to all our stockholders pro rata); |
• |
payment or declaration of any dividend or distribution on any of our capital stock other than dividends or distributions required to be made pursuant to the terms of any of our outstanding preferred stock; |
• |
any entry into a joint venture or similar business alliance involving, or entering into any agreement providing for, the investment, contribution or disposition by the Company or our subsidiaries of assets having a fair market value in excess of $100 million, other than transactions solely between or among the Company and one or more of its subsidiaries; or |
• |
the adoption, approval, issuance or amendment of any poison pill or stockholder rights plan. |
Year Ended |
||||||||
January 3, 2026 |
January 4, 2025 |
|||||||
Audit Fees (1) |
$ |
1,219,605 |
$ |
1,386,000 |
||||
Audit Related Fees (2) |
— |
— |
||||||
Tax Fees (3) |
— |
— |
||||||
All Other Fees (4) |
6,154 |
6,154 |
||||||
Total |
1,225,759 |
1,392,154 |
||||||
(1) |
Audit fees consist of fees billed for professional services performed by Deloitte for the audit of our annual financial statements, the review of interim financial statements and related services that are normally provided in connection with registration statements. |
(2) |
Audit-related fees may consist of fees billed by an independent registered public accounting firm for assurance and related services that are reasonably related to the performance of the audit or review of our consolidated financial statements. There were no such fees incurred in 2025 or 2024. |
(3) |
Tax fees may consist of fees for professional services, including tax consulting and compliance performed by an independent registered public accounting firm. |
(4) |
All other fees consist of fees related to a subscription to online research and disclosure software. |
PART IV
Item 15. Exhibits, Financial Statement Schedules.
(a)(1) See the index to consolidated financial statements provided in Item 8 of this annual report on Form 10-K for a list of the financial statements filed as part of this report.
(2) Financial statement schedules are omitted because they are either not applicable or not material.
(3) The following documents are filed, furnished or incorporated by reference to this report as required by Item 601 of Regulation S-K.
30
31
32
| * | Filed herewith. |
| + | Indicates management contract or compensatory plan. |
| † | The schedules and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company agrees to furnish supplementally a copy of such schedules and exhibits, or any section thereof, to the SEC upon request. |
| ^ | Incorporated by reference to the same titled exhibit to the Registrant’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 4, 2026. |
Item 16. Form 10-K Summary
None.
33
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
| European Wax Center, Inc. | ||||||
| Date: April 27, 2026 |
By: |
/s/ CHRISTOPHER MORRIS | ||||
| Christopher Morris | ||||||
| Chief Executive Officer and Chairman | ||||||
34